Google sister Verily sports another impressive raise, hauling in $700M to support its two big platforms
Since its founding, Google’s sister company Verily has been aiming to reinvent the multibillion-dollar clinical trial business. And now it has a boatload of new cash to do so, as well as potentially make some new deals.
Verily announced Thursday it has completed a $700 million fundraise from its parent company Alphabet, the mega-conglomerate that owns Google and its plethora of businesses, among other investors. The funding will support two main projects at the company: Baseline, which aims to make clinical research more efficient through decentralization, and Verily Health Platforms, an initiative that offers services for disease management.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.